Insulin-like growth factor I correlates with protein intake estimated from the normalized protein catabolic rate in hemodialysis patients

American Journal of Nephrology

Volumn 20, Issue 4, 2000, Pages 255-262

  Lindgren, Björn F ^a,b   Friis, Karin ^a   Ericsson, Folke ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Fresenius Kabi AB   (Sweden)

Author keywords

Hemodialysis; Insulin like growth factor binding protein; Insulin like growth factor I

Indexed keywords

ALBUMIN; PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ADULT; AGED; ALBUMIN BLOOD LEVEL; AMINO ACID TRANSPORT; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIET; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALNUTRITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTAKE; RADIOIMMUNOASSAY; STATISTICS;

EID: 0033824053     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013597     Document Type: Article

References (34)

1. Bergström J: Why are dialysis patients malnourished? Am J Kidney Dis 1995;26:229-241.
2. Ikizler TA, Hakim RM: Nutrition in end-stage renal disease. Kidney Int 1996;50:343-357.
3. Garibotto G, Barreca A, Russo R, Sofia A, Araghi P, Cesarone A, Malaspina M, Fiorino F, Minuto F, Tizianello A: Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients. J Clin Invest 1997;99:97-105.
4. Mitch WE, Medina R, Grieber S, May RC, England BK, Price SR, Bailey JL, Goldberg AL: Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteosomes. J Clin Invest 1994; 93:2127-2133.
5. Anderstam B, Mamoun AH, Södersten P, Bergström J: Middle-sized molecule fractions isolated from uremie ultrafiltrate and normal urine inhibit ingestive behavior in the rat. J Am Soc Nephrol 1996;7:2453-2460.
6. Gutierrez A, Alvestrand A, Wahren J, Bergström J: Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 1990;38:487-494.
7. Bergström J: Nutrition and mortality in hemodialysis. J Am Soc Nephrol 1995;6:1329-1341.
8. Owen WF Jr, Lew NL, Liu Y, Lowric EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993;329:1001-1006.
9. Jacob V, Le Carpentier JE, Salzano S, Naylor V, Wild G, Brown CB, el Nahas AM: IGF-I, a marker of undernutrition in hemodialysis patients. Am J Clin Nutr 1990;52:39-44.
10. Veldhuis JD, Iranmanesh A, Wilkowski MJ, Samojlik E: Neuroendocrine alterations in the somatotropic and lactotropic axes in uremic men. Eur J Endocrinol 1994;131:489-498.
11. Tönshoff B, Edén S, Weiser E: Reduced hepatic growth hormone (GH) expression and increased plasma GH binding protein in experimental uremia. Kidney Int 1994;45:1085-1092.
12. Fouque D, Peng SC, Kopple JD: Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients. Kidney Int 1995;47:876-883.
13. Mak RH, Pak YK: End-organ resistance to growth hormone and IGF-I in epiphyscal chondrocytes of rats with chronic renal failure. Kidney Int 1996;50:400-406.
14. Powell DR, Rosenfeld RG, Baker BK, Liu F, Hintz RL: Serum somatomedin levels in adults with chronic renal failure: The importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum. J Clin Endocrinol Metab 1986;63: 1186-1192.
15. Lindgren BF, Odar-Cederlöf I, Ericsson F, Brismar K: Decreased bioavailability of insulin-like growth factor-I: A cause of catabolism in hemodialysis patients. Growth Regul 1996; 6:137-143.
16. Tönshoff B, Powell DR, Zhao D, Durham SK, Coleman ME, Domene HM, Blum WF, Baxter RC, Moore LC, Kaskel FJ: Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia. Endocrinology 1997;138:938-946.
17. Hawker FH, Stewart PM, Baxter RC, Borkmann M, Tan K, Caterson ID, McWilliam DB: Relationship of somatomedin-C/insulin-like growth factor I levels to conventional nutritional indices in critically ill patients. Crit Care Med 1987;15:732-736.
18. Guler HP, Schmid C, Zapf J, Froesch ER: Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci USA 1989;86:2868-2872.
19. Hall K, Sara VR: Growth and somatomedins. Vitam Horm 1983;40:175-233.
20. Hilding A, Brismar K, Degerblad M, Thoren M, Hall K: Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin ingrowth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. J Clin Endocrinol Metab 1995;80:2646-2652.
21. Bang P: Valid measurements of total IGF concentrations in biological fluids: Recommendations from the 3rd International Symposium on Insulin-Like Growth Factors. Growth Regul 1995;5:66-67.
22. Bang P, Eriksson U, Sara V, Wivall IL, Hall K: Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: Improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol (Copenh) 1991;124:620-629.
23. Povoa G, Roovete A, Hall K: Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol (Copenh) 1984;107: 563-570.
24. Depner TA, Daugirdas JT: Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics. J Am Soc Nephrol 1996;7:780-785.
25. Chumlea WC, Guo SS, Vellas B: Assessment of protein-caloric nutrition; in Kopple JD, Massey SG (eds): Nutritional Management of Renal Disease. Baltimore, Williams & Wilkins, 1997, pp 203-228.
26. Carlmark B, Kromhout D, Reizenstein P: Total body potassium measurements in 230 patients: A study of potassium depletion. Scand J Clin Lab Invest 1975;35:617-623.
27. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985;28:526-534.
28. Daugirdas JT: Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 1993;4: 1205-1213.
29. Brismar K, Gutniak M, Povoa G, Werner S, Hall K: Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus. J Endocrinol Invest 1988;11:599-602.
30. Shinobe M, Sanaka T, Nihei H, Sugino N: IGF-I/IGFBP-1 as an index for discrimination between responder and nonresponder to recombinant human growth hormone in malnourished uremic patients on hemodialysis. Nephron 1997;77:29-36.
31. Lindgren BF: Regulation of Insulin-Like Growth Factor Binding Protein-1 and Implications in Catabolic Conditions: thesis Karolinska Institute. Stockholm, 1997.
32. Frystyk J, Vestbo E, Skjærbaek C, Mogensen CE, Orskov H: Free insulin-like growth factors in human obesity. Metabolism 1995;44(suppl 4):37-44.
33. Ericsson F, Brismar K, Divino J, Lindgren B: Growth hormone increases PCRn in HD patients (abstract A0363). J Am Soc Nephrol 1999;9:70.
34. Landin-Wilhelmsen K, Wilhelmscn L, Lappas G, Rosen T, Lindstedt G, Lundberg PA, Bengtsson BA: Serum insulin-like growth factor I in a random population sample of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxf) 1994;41: 351-357.